10X GENOMICS Ownership

1KJ Stock  EUR 14.11  0.49  3.36%   
10X GENOMICS holds a total of 95.6 Million outstanding shares. The majority of 10X GENOMICS DL outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in 10X GENOMICS DL to benefit from reduced commissions. Hence, institutional investors are subject to a different set of regulations than regular investors in 10X GENOMICS. Please pay attention to any change in the institutional holdings of 10X GENOMICS DL as this could imply that something significant has changed or is about to change at the company. Also note that nearly two million sixty-four thousand eight hundred eighty invesors are currently shorting 10X GENOMICS expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as 10X GENOMICS in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of 10X GENOMICS, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 10X GENOMICS DL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in 10X Stock please use our How to Invest in 10X GENOMICS guide.

10X Stock Ownership Analysis

About 100.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.76. 10X GENOMICS DL had not issued any dividends in recent years. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. 10X GENOMICS operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 852 people. For more info on 10X GENOMICS DL please contact Serge Saxonov at 925 401 7300 or go to http://www.10xgenomics.com.

10X GENOMICS Outstanding Bonds

10X GENOMICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 10X GENOMICS DL uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 10X bonds can be classified according to their maturity, which is the date when 10X GENOMICS DL has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in 10X Stock

10X GENOMICS financial ratios help investors to determine whether 10X Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 10X with respect to the benefits of owning 10X GENOMICS security.